| Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion … S Nazzal, II Smalyukh, OD Lavrentovich, MA Khan International journal of pharmaceutics 235 (1-2), 247-265, 2002 | 359 | 2002 |
| Paclitaxel loaded PEG5000–DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation KK Gill, S Nazzal, A Kaddoumi European Journal of Pharmaceutics and Biopharmaceutics 79 (2), 276-284, 2011 | 204 | 2011 |
| pH-dependent solubility and dissolution behavior of carvedilol—case example of a weakly basic BCS class II drug R Hamed, A Awadallah, S Sunoqrot, O Tarawneh, S Nazzal, ... Aaps Pharmscitech 17, 418-426, 2016 | 203 | 2016 |
| Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients S Nazzal, M Nutan, A Palamakula, R Shah, AA Zaghloul, MA Khan International journal of pharmaceutics 240 (1-2), 103-114, 2002 | 201 | 2002 |
| Controlled release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters S Nazzal, MA Khan International journal of pharmaceutics 315 (1-2), 110-121, 2006 | 195 | 2006 |
| Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS) V Agarwal, A Siddiqui, H Ali, S Nazzal International journal of pharmaceutics 366 (1-2), 44-52, 2009 | 176 | 2009 |
| Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications RS Darweesh, NM Ayoub, S Nazzal International journal of nanomedicine, 7643-7663, 2019 | 139 | 2019 |
| Mixed micelles of PEG2000-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small … KK Gill, A Kaddoumi, S Nazzal European journal of pharmaceutical sciences 46 (1-2), 64-71, 2012 | 132 | 2012 |
| Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system S Nazzal, MA Khan AAPS PharmSciTech 3, 23-31, 2002 | 130 | 2002 |
| PEG–lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication KK Gill, A Kaddoumi, S Nazzal Journal of drug targeting 23 (3), 222-231, 2015 | 115 | 2015 |
| Preparation, characterization, and anticancer effects of simvastatin–tocotrienol lipid nanoparticles H Ali, AB Shirode, PW Sylvester, S Nazzal International journal of pharmaceutics 389 (1-2), 223-231, 2010 | 96 | 2010 |
| Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases γ-tocotrienol oral bioavailability BS Abuasal, C Lucas, B Peyton, A Alayoubi, S Nazzal, PW Sylvester, ... Lipids 47, 461-469, 2012 | 95 | 2012 |
| Sulforaphane as an anticancer molecule: Mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems MM Kamal, S Akter, CN Lin, S Nazzal Archives of Pharmacal Research 43, 371-384, 2020 | 94 | 2020 |
| Cellular uptake, antioxidant and antiproliferative activity of entrapped α-tocopherol and γ-tocotrienol in poly (lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA … S Alqahtani, L Simon, CE Astete, A Alayoubi, PW Sylvester, S Nazzal, ... Journal of colloid and interface science 445, 243-251, 2015 | 94 | 2015 |
| Preparation and characterization of Coenzyme Q10–Eudragit® solid dispersion S Nazzal, N Guven, IK Reddy, MA Khan Drug development and industrial pharmacy 28 (1), 49-57, 2002 | 92 | 2002 |
| Modeling the effect of sonication parameters on size and dispersion temperature of solid lipid nanoparticles (SLNs) by response surface methodology (RSM) A Siddiqui, A Alayoubi, Y El-Malah, S Nazzal Pharmaceutical development and technology 19 (3), 342-346, 2014 | 78 | 2014 |
| Molecular interaction and localization of tocotrienol-rich fraction (TRF) within the matrices of lipid nanoparticles: evidence studies by differential scanning calorimetry (DSC … H Ali, K El-Sayed, PW Sylvester, S Nazzal Colloids and Surfaces B: Biointerfaces 77 (2), 286-297, 2010 | 75 | 2010 |
| D-optimal mixture design: optimization of ternary matrix blends for controlled zero-order drug release from oral dosage forms Y El-Malah, S Nazzal, NM Khanfar Drug development and industrial pharmacy 32 (10), 1207-1218, 2006 | 71 | 2006 |
| Characterization of soft gelatin capsules by thermal analysis S Nazzal, Y Wang International journal of pharmaceutics 230 (1-2), 35-45, 2001 | 70 | 2001 |
| Novel use of Eudragit® NE 30D/Eudragit® L 30D-55 blends as functional coating materials in time-delayed drug release applications Y El-Malah, S Nazzal International journal of pharmaceutics 357 (1-2), 219-227, 2008 | 62 | 2008 |
Alaadin AlayoubiFDAZweryfikowany adres z fda.hhs.gov